hypercholesterolemia, autosomal dominant, 3
hypercholesterolemia, autosomal dominant, 3
Explore linked clinical trials. Standard reference: MONDO:00113694 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS | Arterial Occlusive Diseases, acute coronary syndrome, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hypercholesterolemia, autosomal dominant, 3, myocardial ischemia, vascular disorder | Recruiting | Phase 4 | 2026-10-07 | NCT07612774 | |
| A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma | Arterial Occlusive Diseases, Atheroma, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hypercholesterolemia, autosomal dominant, 3, hyperlipidemia, metabolic disease, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07803679 | |
| Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Inflammation, Insulin Resistance, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diabetes mellitus, endocrine system disorder, familial hypercholesterolemia, glucose metabolism disease, hereditary disease, hypercholesterolemia, autosomal dominant, 3, hyperinsulinism, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-03-12 | NCT04485871 | |
| Genetic Testing and Motivational Counseling for FH | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Hyperlipoproteinemia Type IIa, Hyperlipoproteinemia Type IIb, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hypercholesterolemia, autosomal dominant, 3, hypercholesterolemia, autosomal dominant, type B, hypercholesterolemia, familial, 1, hypercholesterolemia, familial, 4, hyperlipidemia, hyperlipoproteinemia, hyperlipoproteinemia type 3, inborn errors of metabolism, metabolic disease | Active, not recruiting | Not applicable | 2024-12-17 | NCT04656028 |